CIBC Private Wealth Group
TXMD icon

CIBC Private Wealth Group’s TherapeuticsMD TXMD Stock Holding History

CIBC Private Wealth Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$33 Buy
+20
New +$29 ﹤0.01% 3348
2020
Q1 		– Sell
-253
Closed -$31K – 935
2019
Q4 		$31K Buy
253
+50
+25% +$7.19K ﹤0.01% 889
2019
Q3 		$37K Buy
+203
New +$28.6K ﹤0.01% 880
2018
Q4 		– Sell
-332
Closed -$109K – 959
2018
Q3 		$109K Hold
332
– – ﹤0.01% 940
2018
Q2 		$104K Buy
332
+90
+37% +$27.5K ﹤0.01% 1021
2018
Q1 		$59K Hold
242
– – ﹤0.01% 1119
2017
Q4 		$73K Buy
+242
New +$67.4K ﹤0.01% 1095

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIBC Private Wealth Group's TXMD Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in TherapeuticsMD (TXMD) in Q4 2025: 20 shares worth $33. The stake represents ﹤0.01% of the portfolio and ranks #3348 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in TXMD as recently as Q4 2019.

CIBC Private Wealth Group first reported a position in TXMD in Q4 2017 and has held it in 7 quarters since. The position peaked at $109K in Q3 2018. 44 funds tracked by Wall St. Rank hold TXMD as of Q4 2025.

  • CIBC Private Wealth Group held 20 shares of TherapeuticsMD worth $33 as of Q4 2025.
  • TherapeuticsMD was a new CIBC Private Wealth Group position in Q4 2025.
  • TherapeuticsMD made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3348 holding.
  • CIBC Private Wealth Group first reported a position in TherapeuticsMD in Q4 2017 and has held it in 7 quarters since.
  • CIBC Private Wealth Group's TherapeuticsMD position peaked at $109K in Q3 2018.
  • 44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.